A 4052 New Jersey General Assembly · 2022-2023 Regular Session

Establishes three-year sickle cell disease pilot program; appropriates $10,200,000.*

Bill status signed all 5 stages cleared

Introduction

May 2022

Committee Review

Nov 2023

General Assembly Passage

Jun 2023

Senate Passage

Dec 2023

Signed into Law

Jan 2024

Introduced May 19, 2022 Signed Jan 8, 2024

Floor votes

How they voted

This bill passed the Senate by voice vote (no roll call recorded).

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Jan 8, 2024

Signed into law

Approved P.L.2023, c.242.

executive

Dec 21, 2023

Upper · Passed

Passed Senate (Passed Both Houses) (35-0)

upper

Nov 30, 2023

Upper · Passed

Reported out of Senate Committee, 2nd Reading

upper

Nov 27, 2023

Committee

Received in the Senate, Referred to Senate Budget and Appropriations Committee

upper

Jun 30, 2023

Lower · Passed

Passed Assembly (75-0-0)

lower

Jun 22, 2023

Lower · Passed

Reported out of Assembly Committee, 2nd Reading

lower

Jun 5, 2023

Committee

Reported out of Assembly Committee with Amendments and Referred to Assembly Appropriations Committee

lower

May 19, 2022

Introduced

Introduced in the Assembly, Referred to Assembly Health Committee

lower

5 primary · 18 co-sponsors